Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.33T
Market cap1.33T
Price-Earnings ratio
45.13
Price-Earnings ratio45.13
Dividend yield
0.49%
Dividend yield0.49%
Average volume
2.46M
Average volume2.46M
High today
$1,449.68
High today$1,449.68
Low today
$1,393.00
Low today$1,393.00
Open price
$1,426.41
Open price$1,426.41
Volume
5.25M
Volume5.25M
52 Week high
$1,449.68
52 Week high$1,449.68
52 Week low
$812.25
52 Week low$812.25

Stock Snapshot

With a market cap of 1.33T, Eli Lilly(LLY) trades at $1,414.51. The stock has a price-to-earnings ratio of 45.13 and currently yields dividends of 0.49%.

During the trading session on 2026-10-30, Eli Lilly(LLY) shares reached a daily high of $1,449.68 and a low of $1,393.00. At a current price of $1,414.51, the stock is +1.5% higher than the low and still -2.4% under the high.

Trading activity shows a volume of 5.25M, compared to an average daily volume of 2.46M.

The stock's 52-week range extends from a low of $812.25 to a high of $1,449.68.

The stock's 52-week range extends from a low of $812.25 to a high of $1,449.68.

LLY News

Investing.com 25m
Cathie Wood’s ARK sells Eli Lilly stock, buys Tempus AI and Coinbase - Investing.com

...

Cathie Wood’s ARK sells Eli Lilly stock, buys Tempus AI and Coinbase - Investing.com
The Motley Fool 6h
Eli Lilly Is Now Worth as Much as Warren Buffett's Berkshire Hathaway. Can the Rally Keep Going?

Warren Buffett is no longer involved in running Berkshire Hathaway (BRKA +0.15%)(BRKB +0.66%), but the company he built is nothing short of impressive. With a r...

Eli Lilly Is Now Worth as Much as Warren Buffett's Berkshire Hathaway. Can the Rally Keep Going?
Benzinga 7h
Eli Lilly 'Deserves' Stock Upside: Analyst

Eli Lilly and Co. (NYSE:LLY) stock is trading higher on Friday on continued momentum following better-than-expected third-quarter financial results and a guidan...

Eli Lilly 'Deserves' Stock Upside: Analyst

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

Simply Wall St 8h
Will Raised Guidance Change Eli Lilly Stock Narrative

Eli Lilly lifted its 2026 revenue outlook to US$91b to US$92b after third quarter sales of US$24.4b and net income of US$6.45b, supported by strong demand for M...

Benzinga 14h
LLY Stock Hits Record as CEO Says Middle-Income Consumers Are Driving Pharma’s ‘Largest New Category Expansion’

Eli Lilly and Co. (NYSE:LLY) shares closed at a record Thursday after CEO David Ricks said demand for weight-loss medicines is extending beyond very-high-net-wo...

LLY Stock Hits Record as CEO Says Middle-Income Consumers Are Driving Pharma’s ‘Largest New Category Expansion’
The Motley Fool 1d
Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction

Eli Lilly's (LLY +5.97%) third-quarter revenue rose 39% to about $24.4 billion, as a 53% jump in volume swamped a 15% drop in realized prices. Shares were up ab...

Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction
The Wall Street Journal 1d
Health Care Roundup: Market Talk

george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
24/7 Wall St. 1d
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher

Investing Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher Merck (NYSE:MRK | MRK Price Prediction) is t...

Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher
Simply Wall St 1d
Eli Lilly Retatrutide Beat A Rival Drug In Phase 3 Trial

Eli Lilly (NYSE: LLY) reported that retatrutide outperformed Novo Nordisk's Ozempic in a major Phase 3 diabetes trial. The business unveiled plans to combine U...

TipRanks 1d
Eli Lilly Stock Soars as Financial Results Crush Wall Street Estimates

Shares of Eli Lilly (LLY) are up 8% after the pharmaceutical company reported quarterly financial results that trounced Wall Street’s estimates. The Indianapoli...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.